Claims
- 1. A method for detecting a biological material in a sample, the method comprising:
(a) contacting the biological material in the sample with a magnetic transducer comprising a superparamagnetic nanoparticle comprising Fe atoms and Au atoms distributed in a solid solution with no observable segregation into Fe-rich or Au-rich phases or regions, and a binding agent that binds the biological material, to yield a reaction mixture comprising a bound transducer complex comprising the superparamagnetic nanoparticle and the biological material, and an unbound magnetic transducer; (b) applying an magnetic field to separate the bound transducer complex from at least one other component of the reaction mixture; and (c) detecting the bound transducer complex, wherein detection of the bound transducer complex is indicative of the presence of the biological material in the sample.
- 2. The method of claim 1 wherein the bound transducer complex comprises a plurality of magnetic transducers.
- 3. The method of claim 1 wherein the magnetic transducer comprises a plurality of binding agents.
- 4. The method of claim 3 wherein the binding agents are the same or different.
- 5. The method of claim 1 wherein the superparamagnetic nanoparticle is characterized by a large magnetic susceptibility per particle volume.
- 6. The method of claim 1 wherein the magnetic transducer comprises a population of magnetic transducers comprising superparamagnetic nanoparticles characterized by uniform size and magnetic properties.
- 7. The method of claim 1 wherein detecting the bound transducer complex comprises evaluating the relative mobility of the bound transducer complex in a magnetic field.
- 8. The method of claim 1 wherein the bound transducer complex is separated from another magnetic component of the reaction mixture.
- 9. The method of claim 8 wherein the bound transducer complex is separated from an unbound magnetic transducer.
- 10. The method of claim 1 comprising contacting first and second biological materials in the sample with first and second magnetic transducers, each magnetic transducer comprising a superparamagnetic nanoparticle comprising Fe atoms and Au atoms distributed in a solid solution with no observable segregation into Fe-rich or Au-rich phases or regions, said first magnetic transducer further comprising a first binding agent that binds the first biological material and said second magnetic transducer further comprising a second binding agent that binds the second biological material, to yield a reaction mixture comprising a first bound transducer complex comprising the superparamagnetic nanoparticle and the first biological material, a second bound transducer complex comprising the superparamagnetic nanoparticle and the second biological material, and unbound first and second magnetic transducers; wherein application of the magnetic field causes the first bound transducer complex to separate from the second bound transducer complex.
- 11. The method of claim 1 wherein the bound transducer complex is separated from a diamagnetic component of the reaction mixture.
- 12. The method of claim 1 wherein the bound transducer complex is optically detected.
- 13. The method of claim 12 wherein the bound transducer complex is detected using phase contrast imaging.
- 14. The method of claim 13 wherein the superparamagnetic nanoparticle has a diameter greater than about 50 nm.
- 15. The method of claim 13 wherein the superparamagnetic nanoparticles are tagged with an optically active molecule or semiconductor quantum dots to provide them with resonant optical response.
- 16. The method of claim 13 wherein the bound transducer complex is detected by tracking in liquid.
- 17. The method of claim 13 wherein the bound transducer complex is detected by collection on a substrate and imaging.
- 18. The method of claim 1 wherein the bound transducer complex is collected on a substrate and detected using transmission electron microscopy.
- 19. The method of claim 18 wherein the superparamagnetic nanoparticle has a diameter greater than about 5 nm.
- 20. The method of claim 12 wherein step (a) further comprises contacting the biological material in the sample with a functionalized optical marker comprising a binding agent that binds the biological material, to yield a reaction mixture comprising a bound transducer complex comprising the superparamagnetic nanoparticle, the optical marker and the biological material, an unbound magnetic transducer, and an unbound optical marker; wherein application of the magnetic field causes the bound transducer complex to separate from the unbound optical marker.
- 21. The method of claim 20 wherein the binding agent of the functionalized optical marker binds to the biological target.
- 22. The method of claim 20 wherein step (c) comprises detecting an optical marker in the bound transducer complex, wherein the presence of the optical marker in the bound transducer complex is indicative of the presence of the biological material in the sample.
- 23. The method of claim 20 wherein the binding agent of the magnetic transducer and the binding agent of the optical marker are the same or different.
- 24. The method of claim 20 wherein the optical marker comprises an Au particle.
- 25. The method of claim 24 wherein the Au particle has a diameter greater that about 20 nm.
- 26. The method of claim 20 wherein the bound transducer complex is detected using phase contrast imaging.
- 27. The method of claim 26 wherein the bound transducer complex is detected by tracking in liquid.
- 28. The method of claim 26 wherein the bound transducer complex is detected by collection on a substrate and imaging.
- 29. The method of claim 20 wherein the bound transducer complex is collected on a substrate and detected using transmission electron microscopy.
- 30. The method of claim 20 wherein the optical marker is detected in the presence of unbound magnetic transducers.
- 31. The method of claim 30 wherein the optical marker comprises an Au particle, and wherein transmission electron microscopy is used to detect the presence of the bound transducer complex.
- 32. The method of claim 30 wherein the bound transducer complex is further separated from the unbound magnetic transducer.
- 33. The method of claim 20 wherein contacting the biological material in the sample with the magnetic transducer and the functionalized optical marker yields a reaction mixture comprising a first bound transducer complex comprising the superparamagnetic nanoparticle, the optical marker and the biological material, a second bound transducer complex comprising the superparamagnetic nanoparticle, the biological material, but no optical marker; an unbound magnetic transducer, and an unbound optical marker; wherein application of the magnetic field causes separation of the first bound transducer complex, the second bound transducer complex, the unbound optical marker and the unbound magnetic transducer.
- 34. The method of claim 33 wherein the binding agent component of the functionalized optical marker is different from the binding agent component of the magnetic transducer.
- 35. The method of claim 33 comprising detecting the first and second bound transducer complexes.
- 36. A magnetic transducer comprising a superparamagnetic nanoparticle comprising Fe atoms and Au atoms distributed in a solid solution with no observable segregation into Fe-rich or Au-rich phases or regions, and a binding agent that binds the biological material.
- 37. A device for separating magnetic nanoparticles from diamagnetic nanoparticles comprising:
a channel comprising a recessed cavity comprising a substrate; and a magnetic field adjacent the recessed cavity; wherein the device is operable to provide i) a liquid comprising magnetic and diamagnetic nanoparticles flowing through the cavity and ii) a diffusion barrier comprising a stagnant liquid layer in the recessed cavity, and wherein the magnetic field provides for collection of one or more magnetic nanoparticles on the substrate.
- 38. The device of claim 37 wherein the number of magnetic nanoparticles collected on the substrate is controlled by a process comprising controlling the flow rate of the liquid through the cavity.
- 39. The device of claim 37 wherein the number of magnetic nanoparticles collected on the substrate is controlled by a process comprising controlling the thickness of the diffusion barrier.
- 40. The device of claim 39 wherein the thickness of the diffusion barrier is controlled by controlling the depth of the recessed cavity.
- 41. A method for separating magnetic nanoparticles from diamagnetic nanoparticles comprising:
introducing a liquid comprising magnetic nanoparticles and diamagnetic nanoparticles a channel comprising a recessed cavity comprising a substrate; selecting a flow rate of the liquid through the channel so as to create a diffusion barrier comprising a stagnant liquid layer in the recessed cavity; and applying a magnetic field adjacent the recessed cavity such that the magnetic nanoparticles are collected on the substrate.
- 42. A device for detection of biological materials comprising:
means for magnetically separating components of a reaction mixture, the reaction mixture comprising a bound transducer complex comprising a superparamagnetic nanoparticle comprising Fe atoms and Au atoms distributed in a solid solution with no observable segregation into Fe-rich or Au-rich phases or regions, bound to a biological material; and means for detecting the bound transducer complex, wherein detection of the bound transducer complex is indicative of the presence of the biological material in the sample.
- 43. The device of claim 42 wherein the means for detecting the bound transducer complex comprises means for detecting the optical signature of the bound transducer complex.
- 44. The device of claim 42 wherein the means for detecting the bound transducer complex comprises means for detecting the relative magnetophoretic mobility of the bound transducer complex.
Parent Case Info
[0001] This application claims the benefit of U.S. Provisional Applications Serial Nos. 60/358,983, filed 22 Feb. 2002, 60/388,221, filed 13 Jun. 2002, and 60/392,192, filed 28 Jun. 2002, each of which is incorporated herein by reference in its entirety.
Provisional Applications (3)
|
Number |
Date |
Country |
|
60392192 |
Jun 2002 |
US |
|
60388221 |
Jun 2002 |
US |
|
60358983 |
Feb 2002 |
US |